Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed)
ID: PAR-24-157Type: BOTH
Overview

Topic

Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed)

Agency

Department of Health and Human ServicesNational Institutes of Health

Program

Type: STTRPhase: BOTHYear: 2024

Topic Link

https://www.sbir.gov/node/2587407

Additional Information

https://grants.nih.gov/grants/guide/PA-files/PAR-24-157.html
Timeline
  1. 1
    Release Feb 29, 2024 12:00 AM
  2. 2
    Open Mar 5, 2024 12:00 AM
  3. 3
    Next Submission Due Sep 5, 2024 12:00 AM
  4. 4
    Close Jan 6, 2027 12:00 AM
Description

The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for addressing health inequities in clinical diagnostics. The purpose of this funding opportunity is to encourage small businesses to develop improved or alternative clinical diagnostics that incorporate diverse patient groups and address health disparities. The goal is to lay the groundwork for more equitable clinical diagnostics that lead to improved health, healthcare delivery, and the elimination of health disparities. The research objectives include developing clinical diagnostics that are accessible to populations that experience health disparities, considering social determinants of health during the development process, and including input from relevant populations. The funding opportunity accepts various types of projects, such as novel technologies, analytics or bioinformatics, clinical decision support tools, and pilot or small-scale projects. The funding is available through the Small Business Innovation Research (SBIR) program, with Phase I and Phase II funding options. The open date for applications is March 5, 2024, and the close date is January 6, 2027. More information can be found on the grants.gov website.

Files
No associated files provided.
Similar Opportunities
Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for addressing health inequities in clinical diagnostics. The purpose of this funding opportunity is to encourage small businesses to develop improved or alternative clinical diagnostics that incorporate diverse patient groups and eliminate health disparities. The research should focus on identifying and addressing issues within clinical diagnostics that perpetuate health inequity. The projects may involve existing clinical diagnostics or propose new ones. Applicants are encouraged to consider social determinants of health during the development process and include input from relevant populations that experience health disparities. The funding opportunity accepts different types of projects, including those that address pigment variation in imaging devices, utilize equitable parameters instead of non-biological parameters like race, improve analytics or bioinformatics, develop clinical decision support tools, validate new technology, or further develop existing technology. The funding is available through the Small Business Innovation Research (SBIR) program, with Phase I and Phase II funding options. The open date for applications is March 5, 2024, and the close date is January 6, 2027. For more information, including specific research objectives and areas of interest, interested parties can visit the solicitation agency URL provided.
Addressing Health Inequities in Clinical Diagnostics (R43/R44 Clinical Trials Not Allowed) - https://grants.nih.gov/grants/guide/PA-files/PAR-24-158.html
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for addressing health inequities in clinical diagnostics through their Small Business Innovation Research (SBIR) program. The purpose of this funding opportunity is to encourage small businesses to develop improved or alternative clinical diagnostics that incorporate diverse patient groups and address health disparities. The goal is to lay the groundwork for more equitable clinical diagnostics that lead to improved health, healthcare delivery, and the elimination of health disparities. The research objectives include developing clinical diagnostics that are accessible to populations that experience health disparities, considering social determinants of health during the development process, and including input from relevant populations. The funding opportunity accepts various types of projects, such as novel technologies addressing known issues in existing diagnostics, projects addressing health disparities in analytics or bioinformatics, and pilot or small-scale projects validating new technology. The funding is divided into different phases, including Phase I to establish technical feasibility and Phase II for further development and commercialization. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the Sexual & Gender Minority Research Office (SGMRO) are also participating in this funding opportunity, each with their specific research priorities. The National Human Genome Research Institute (NHGRI) encourages comprehensive genomics research with commercial potential. The solicitation is currently open, with multiple application due dates throughout the year. For more information, refer to the solicitation agency URL provided.
Addressing Health Inequities in Clinical Diagnostics (R43/R44 Clinical Trials Not Allowed) - https://grants.nih.gov/grants/guide/PA-files/PAR-24-158.html
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for addressing health inequities in clinical diagnostics through their Small Business Innovation Research (SBIR) program. The purpose of this funding opportunity is to encourage small businesses to develop improved or alternative clinical diagnostics that address health disparities created by clinical laboratory assays and point-of-care devices that fail to incorporate diverse patient groups. The goal is to develop clinical diagnostics that are accessible to populations that experience health disparities and to eliminate health inequities. The research objectives include developing clinical diagnostics that meet or exceed the quality of existing diagnostics, considering social determinants of health during the development process, and including input from relevant populations that experience health disparities. The funding opportunity accepts various types of projects, such as novel technologies addressing known issues in existing diagnostics, projects addressing health inequities in analytics or bioinformatics, and pilot or small-scale projects validating new technology. The funding is available for both Phase I and Phase II projects, with the option for a Fast Track application. The National Institute of Arthritis and Musculoskeletal and Skin Diseases, the Sexual & Gender Minority Research Office, and the National Human Genome Research Institute are also participating in this funding opportunity.
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for technologies that improve minority health and eliminate health disparities. The purpose of this funding opportunity is to support small businesses in developing technologies, services, and products that engage and empower individuals and communities, with a focus on African Americans, Hispanics, American Indians and Alaska Natives, Asian Americans, Native Hawaiians and Pacific Islanders, disadvantaged socioeconomic groups, underserved rural populations, and sexual and gender minorities. The goal is to lay the groundwork for sustainable health-promoting activities and interventions that lead to improved health, healthcare delivery, and the elimination of health disparities. The research objectives include improving access to care, developing culturally attuned interventions, detecting and measuring unhealthy social and environmental exposures, engaging and empowering individuals and communities, promoting precision medicine, utilizing digital health technologies, and strengthening infrastructure and workforce for delivering care. The funding is available through the Small Business Innovation Research (SBIR) program, and the solicitation is open until December 10, 2026. For more information, visit the grants.gov website or the National Institutes of Health's solicitation agency URL.
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for technologies that improve minority health and eliminate health disparities. The purpose of this funding opportunity is to support small businesses in developing technologies, services, and products that engage and empower individuals and communities, with a focus on African Americans, Hispanics, American Indians and Alaska Natives, Asian Americans, Native Hawaiians and Pacific Islanders, disadvantaged socioeconomic groups, underserved rural populations, and sexual and gender minorities. The goal is to lay the groundwork for sustainable health-promoting activities and interventions that lead to improved health, healthcare delivery, and the elimination of health disparities. The research objectives include improving access to care, developing culturally attuned interventions, detecting and measuring unhealthy social and environmental exposures, engaging and empowering individuals and communities, and utilizing digital health technologies. The funding is available through the Small Business Innovation Research (SBIR) program, and the solicitation is open until December 10, 2026. For more information, visit the solicitation agency URL: [link](https://grants.nih.gov/grants/guide/RFA-files/RFA-MD-24-007.html).